Ethan Russo is a board-certified neurologist and psychopharmacology researcher who has been a central figure in cannabis medicine for over 25 years. As Senior Medical Advisor at GW Pharmaceuticals, he contributed to the development of Sativex (nabiximols) and Epidiolex. Russo is best known for his work on the "entourage effect" — he has been the most prominent scientific advocate for the therapeutic importance of terpenes and minor cannabinoids in cannabis medicine, arguing that whole-plant preparations are superior to isolated compounds for many indications. His concept of "clinical endocannabinoid deficiency" (CECD) proposes that conditions like migraine, fibromyalgia, and IBS may result from insufficient endocannabinoid tone. Russo is a prolific author and sought-after speaker who has helped translate cannabinoid science for clinical audiences worldwide.
Key Contributions
1Proposed and developed the "clinical endocannabinoid deficiency" (CECD) hypothesis for migraine, fibromyalgia, and IBS
2Authored the most comprehensive review of terpene pharmacology in cannabis ("Taming THC," 2011)
3Contributed to the development of Sativex (nabiximols) at GW Pharmaceuticals
4Established the historical and ethnobotanical record of cannabis as medicine across cultures
5Demonstrated that β-caryophyllene is a dietary cannabinoid via CB2 agonism
6Proposed that CBD's anti-anxiety effects counteract THC-induced anxiety via 5-HT1A agonism
Selected Publications
Taming THC: Potential Cannabis Synergy and Phytocannabinoid-Terpenoid Entourage Effects
2,900 citations
British Journal of Pharmacology · 2011
Comprehensive review proposing that cannabis terpenes and minor cannabinoids synergize with THC and CBD to produce therapeutic effects greater than isolated compounds. Detailed pharmacological profiles of myrcene, limonene, linalool, β-caryophyllene, and α-pinene. The foundational paper for the modern entourage effect concept.
Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes
780 citations
Cannabis and Cannabinoid Research · 2016
Updated review of the clinical endocannabinoid deficiency (CECD) hypothesis, presenting evidence that migraine, fibromyalgia, and IBS share features consistent with insufficient endocannabinoid tone. Proposes cannabis-based medicines as rational treatments for these conditions.
Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?
1,200 citations
Journal of Cannabis Therapeutics · 2001
Early paper arguing that whole-plant cannabis extracts are therapeutically superior to isolated THC, based on the synergistic interactions between cannabinoids, terpenes, and flavonoids. Laid the groundwork for the development of Sativex as a whole-plant extract.
